abstract |
The invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing (E) -7- [4-fluorophenyl) -6-i-propyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl acid. ] - (3R, 5S) -3,5-dihydroxyhept-6-enoic or a pharmaceutically acceptable salt thereof as an active ingredient and an inorganic salt in which the cation is multivalent; |